{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:31:11Z","timestamp":1792089071947,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jiph.2024.04.027","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T12:40:00Z","timestamp":1715172000000},"page":"102443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Global mortality of chronic liver diseases attributable to Hepatitis B virus and Hepatitis C virus infections from 1990 to 2019 and projections to 2030."],"prefix":"10.1016","volume":"17","author":[{"given":"Tsong-Yih","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Duc","family":"Huy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3886-9484","authenticated-orcid":false,"given":"Jeffrey","family":"Mayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Liang","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Mai Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhi","family":"Thi Hong Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linh","family":"Nguyen Hoai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linh","family":"Thi My Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Mao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdikani Ahmed","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Jung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0818-7175","authenticated-orcid":false,"given":"Chung-Chien","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2024.04.027_bib1","unstructured":"World Health Organization. Combating hepatitis B and C to reach elimination by 2030 2014. https:\/\/www.who.int\/publications-detail-redirect\/combating-hepatitis-b-and-c-to-reach-elimination-by-2030 (accessed December 16, 2023)."},{"key":"10.1016\/j.jiph.2024.04.027_bib2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2024.04.027_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jiph.2024.04.027_bib4","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Sheena","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jiph.2024.04.027_bib5","unstructured":"Europe WHORO for. Action plan for the health sector response to viral hepatitis in the WHO European Region. World Health Organization. Regional Office for Europe; 2017."},{"key":"10.1016\/j.jiph.2024.04.027_bib6","unstructured":"World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021 2021. https:\/\/www.who.int\/publications-detail-redirect\/9789240027077 (accessed December 16, 2023)."},{"key":"10.1016\/j.jiph.2024.04.027_bib7","unstructured":"World Health Organization. Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030 2022. https:\/\/www.who.int\/publications-detail-redirect\/9789240053779 (accessed December 16, 2023)."},{"key":"10.1016\/j.jiph.2024.04.027_bib8","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/v14061325","article-title":"Direct-acting antiviral agents for Hepatitis C virus infection-from drug discovery to successful implementation in clinical practice","volume":"14","author":"Dietz","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jiph.2024.04.027_bib9","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2147\/CLEP.S389853","article-title":"Global patterns and trends in total burden of Hepatitis B from 1990 to 2019 and predictions to 2030","volume":"14","author":"Zhang","year":"2022","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jiph.2024.04.027_bib10","unstructured":"World Health Organization. Monitoring and evaluation for viral hepatitis B and C: recommended indicators and framework 2016. https:\/\/www.who.int\/publications-detail-redirect\/9789241510288 (accessed December 16, 2023)."},{"issue":"1","key":"10.1016\/j.jiph.2024.04.027_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/1478-7954-10-1","article-title":"Modeling causes of death: an integrated approach using CODEm","volume":"10","author":"Foreman","year":"2012","journal-title":"Popul Health Metr"},{"key":"10.1016\/j.jiph.2024.04.027_bib12","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","article-title":"Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950\u20132019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2024.04.027_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41597-023-02253-5","article-title":"Global trends and forecasts of breast cancer incidence and deaths","volume":"10","author":"Xu","year":"2023","journal-title":"Sci Data"},{"key":"10.1016\/j.jiph.2024.04.027_bib14","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1007\/s12072-023-10503-2","article-title":"Contribution of alcohol use to the global burden of cirrhosis and liver cancer from 1990 to 2019 and projections to 2044","volume":"17","author":"Liu","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jiph.2024.04.027_bib15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/ijc.33617","article-title":"Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039","volume":"149","author":"Yu","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jiph.2024.04.027_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12874-020-01133-5","article-title":"An R package for an integrated evaluation of statistical approaches to cancer incidence projection","volume":"20","author":"Knoll","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jiph.2024.04.027_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40364-020-00195-3","article-title":"Trends and projections of kidney cancer incidence at the global and national levels, 1990\u20132030: a Bayesian age-period-cohort modeling study","volume":"8","author":"Du","year":"2020","journal-title":"Biomark Res"},{"key":"10.1016\/j.jiph.2024.04.027_bib18","author":"Organization","year":"2016","journal-title":"Glob Health Sect Strategy Viral Hepat 2016-2021 Towards End Viral Hepat"},{"key":"10.1016\/j.jiph.2024.04.027_bib19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.patbio.2009.11.002","article-title":"Hepatitis B vaccination in children: the Taiwan experience","volume":"58","author":"Ni","year":"2010","journal-title":"Pathol Biol"},{"key":"10.1016\/j.jiph.2024.04.027_bib20","doi-asserted-by":"crossref","first-page":"8131","DOI":"10.1016\/j.vaccine.2018.10.005","article-title":"Vaccine-preventable disease control in the People\u2019s Republic of China: 1949-2016","volume":"36","author":"Yu","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jiph.2024.04.027_bib21","unstructured":"World Health Organization. Frequently asked questions on Hepatitis B vaccination in China 2014. https:\/\/www.who.int\/hongkongchina\/news\/detail\/18\u201308-2014-frequently-asked-questions-on-hepatitis-b-vaccination-in-china (accessed December 16, 2023)."},{"key":"10.1016\/j.jiph.2024.04.027_bib22","unstructured":"World Health Organization. Regional Office for the Western Pacific. Regional action plan for viral hepatitis in the Western Pacific 2016\u20132020: a priority action plan for awareness, surveillance, prevention and treatment of viral hepatitis in the Western Pacific Region 2016. https:\/\/www.who.int\/publications-detail-redirect\/9789290617617 (accessed December 16, 2023)."},{"key":"10.1016\/j.jiph.2024.04.027_bib23","article-title":"The impact of immigration on hepatitis B burden in the United States: a modelling study","volume":"22","author":"Razavi-Shearer","year":"2023","journal-title":"Lancet Reg Health \u2013 Am"},{"key":"10.1016\/j.jiph.2024.04.027_bib24","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/jamacardio.2019.4187","article-title":"Association between aging of the us population and heart disease mortality from 2011 to 2017","volume":"4","author":"Sidney","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jiph.2024.04.027_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/aje\/155.4.323","article-title":"Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women","volume":"155","author":"Donato","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jiph.2024.04.027_bib26","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jiph.2024.04.027_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jhin.2004.06.014","article-title":"Medical procedures and the risk of iatrogenic hepatitis C infection: case-controlled study in north-eastern Poland","volume":"58","author":"Chlabicz","year":"2004","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jiph.2024.04.027_bib28","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(14)61059-X","article-title":"All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study","volume":"384","author":"Manns","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2024.04.027_bib29","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S2468-1253(21)00263-6","article-title":"The impact of COVID-19 on hepatitis services and civil society organisations","volume":"6","author":"Wingrove","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jiph.2024.04.027_bib30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jiph.2024.04.027_bib31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034124001400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034124001400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T04:27:59Z","timestamp":1718684879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034124001400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1876034124001400"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2024.04.027","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global mortality of chronic liver diseases attributable to Hepatitis B virus and Hepatitis C virus infections from 1990 to 2019 and projections to 2030.","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2024.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"102443"}}